CooperVision demonstrated its role as a leader in myopia management at Academy 2024 in Indianapolis last week, which coincided with the fifth anniversary of MiSight® 1 day’s FDA approval.* This milestone was celebrated at the 2024 Myopia Luminaries Forum, where leading eye care professionals (ECPs) gathered to highlight groundbreaking achievements in myopia management, discuss the latest scientific advancements, and reflect on the significant impact MiSight® 1 day has made over the past five years in correcting and helping to protect the vision and eye health of age-appropriate children with myopia across the U.S.*†‡1,2
"Celebrating this five-year milestone with some of the brightest minds in the industry was a meaningful way to honor this journey,” said Justin Kwan, OD, FAAO, Head, Myopia Management, CooperVision. “Being the first to market is never easy, but when it comes to children’s eye health, it’s essential. Taking the time to reflect on the tremendous work of the past five years and building excitement for the future was the perfect way to kick off Academy this year."*¶1
Prominent experts in the field of myopia spoke at the event, which included:
Key scientific updates in the field from Maria Liu, Ph.D., associate professor at the University of California, Berkeley, followed by an engaging Q&A session.
Practical insights and real-world results into the impact of myopia management from Carlee Young, OD, FAAO.
Katherine Schuetz, OD, then facilitated a panel that featured interviews with both parents and children, offering authentic feedback on how MiSight® 1 day has positively influenced their daily lives and shaped their future vision health.
The event was designed around an elementary school theme, which tied into the “CooperVision Elementary” booth on the Academy show floor. This playful yet purposeful concept highlighted the necessity of early intervention in childhood myopia, reinforcing the idea that timely action is crucial for effective management and long-term eye health in young patients.2
For more information, visit MiSight.com.
